TRILUMINATE
2023
Transcatheter Repair for Patients with Tricuspid Regurgitation
In 350 patients with severe symptomatic tricuspid regurgitation, transcatheter tricuspid repair improved quality of life compared with medical therapy.
Result
Efficacy: Hierarchical composite (death, surgery, HF hospitalisation, quality of life)Win ratio 1.48
Below 1 favours medical therapy, above 1 favours transcatheter tricuspid repair.
Also reported: Driven by quality of life; no reduction in death or HF hospitalisation.
- Subtopic
- Tricuspid
- Design
- RCT
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ESC 2024 CCSESC 2025 VHD
- Source
- Sorajja P, et al. N Engl J Med. 2023;388(20):1833-1842.doi 10.1056/NEJMoa2300525
Discussion & critique
Symptom benefit only: no hard-outcome signal yet. Whether quality-of-life improvement alone justifies the intervention is debated.